CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.

Vanguard International Stock Index-Total Intl Stock Indx

Investment Managers Ser Tr-WCM Focused International Growth Fd

Europacific Growth Fund

Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund

iShares Core MSCI EAFE ETF

iShares MSCI Eafe ETF

Fidelity Series International Growth Fund

Fidelity International Index Fund

JP Morgan ETF Tr-BetaBuilders Developed Asia ex-Japan ETF

Vanguard Intl Equity Index Fds-FTSE All World ex U.S. Index Fund

CSL Ltd

Dr. Paul F. McKenzie Ph.D.

MD, CEO & Executive Director

Ms. Joy Carolyn Linton B.Com., BComm, GAICD, Grad Dip AFI

Interim Executive Vice President of CSL Behring

Mr. Andy  Schmeltz

Executive Vice President of CSL Behring Business Unit (Leave of Absence)

Mr. John A. G. Levy CPA

Interim Chief Financial Officer

Chris  Cooper

Head of Investor Relations

Mr. Gregory  Boss B.S., BS(Hons), J.D.

Executive VP of Legal & General Counsel

Ms. Roanne  Parry

Chief Human Resources Officer

Dr. Andrew D. Nash BSc (Hons), GAICD, Ph.D.

Senior Vice President of Research

Dr. William  Mezzanotte M.D., M.P.H.

Executive VP & Head of Research and Development

Mr. Mark  Hill B.A., M.B.A.

Chief Digital Information Officer & Executive VP

CSL's next earnings is on October 30, 2025 (After Market Close)

CSL's latest dividend is 2.19 AUD on September 9, 2024

CSL Ltd (CSL) Stock Analysis, Discussion Forum and Financial Metrics - ASX Exchange

CSL Ltd (CSL) Earnings Report Date and History | ASX

CSL's next earnings is on October 30, 2025 (After Market Close)

When is the earnings report for CSL?

CSL Earnings History

CSL's latest dividend is 2.19 AUD on September 9, 2024

CSL Stock Discussion Forum and Message Board

News for ASX: CSL